JUN 28, 2021 8:03 AM PDT

Could Deep Brain Stimulation Treat Schizophrenia?

WRITTEN BY: Annie Lennon

From a new case study, researchers from Johns Hopkins University have found that deep brain stimulation may be able to improve symptoms of schizophrenia for at least one year among patients with treatment-resistant variants of the condition. 

Schizophrenia is a chronic neurological disorder that affects less 1% of the US population. Symptoms include delusions, hallucinations, disorganized speech and trouble with thinking and feeling motivated. Although there is currently no cure for the condition, symptoms can be managed with medications and therapy. Between a fifth and half of patients, however, who have severe symptoms of schizophrenia do not respond to current treatments. 

Finding alternative ways to manage symptoms of the condition are thus crucial. As such, given success in deep brain stimulation in treating various neurological disorders including Parkinson’s disease, researchers thought to see whether it could also benefit patients with schizophrenia. 

For the case study, the researchers treated a 35-year-old woman with treatment-resistant paranoid schizophrenia alongside obsessive-compulsive disorder. Her symptoms included persistent auditory and visual hallucinations, thought broadcasting (a person believing their thoughts can be heard by others) and persecutory delusions. Antipsychotic medications, such as clozapine, did not reduce her symptoms. 

For the treatment, the researchers used the same type of brain stimulation hardware used to treat Parkinson's disease and other movement disorders. In particular, they targeted the woman’s substantia nigra pars reticulata, a part of the brain responsible for the control of learning, executive functioning and emotions. 

Immediately after the beginning of the deep brain stimulation treatment, the patient reported complete resolution of her hallucinations. These improvements remained at a year-long follow-up, with no significant complications or adverse reactions related to the treatment having been reported. Due to the treatment and improved quality of life, the patient is now in the process of reducing her antipsychotic medications. 

While promising results, the researchers say that long-term efficacy needs to be seen in larger trials before any conclusions can be drawn. Nevertheless, they say their results show that deep brain stimulation may be more effective for treating schizophrenia than conventional treatments. 

 

Sources: Psychiatry.orgNeuroscience NewsBiological Psychiatry

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
JUL 08, 2021
Cancer
Activating p53 May Boost Efficacy of Cancer Immunotherapy
JUL 08, 2021
Activating p53 May Boost Efficacy of Cancer Immunotherapy
Pharmacological activation of the p53 protein in cancer cells leads to an anti-tumor immune response in lab tests. These ...
JUL 12, 2021
Drug Discovery & Development
Testosterone Supplements Reduce Heart Attack and Stroke Risk
JUL 12, 2021
Testosterone Supplements Reduce Heart Attack and Stroke Risk
Taking testosterone supplements significantly reduces risk of heart attack and stroke among men with low levels of the h ...
JUL 27, 2021
Drug Discovery & Development
Immune related genes influence antipsychotic-induced weight gain.
JUL 27, 2021
Immune related genes influence antipsychotic-induced weight gain.
Mental disorders such as Schizophrenia and Bipolar disorder are currently incurable, but some symptoms can be treated wi ...
AUG 05, 2021
Drug Discovery & Development
A Smartphone App that Identifies Disease-Carrying, Insecticide-Resistant Mosquitos.
AUG 05, 2021
A Smartphone App that Identifies Disease-Carrying, Insecticide-Resistant Mosquitos.
Mosquito-borne diseases can lead to serious disability or death. These diseases, which include Malaria, Zika, West Nile ...
AUG 15, 2021
Drug Discovery & Development
Diabetes Drug May Reduce Alzheimer's Risk
AUG 15, 2021
Diabetes Drug May Reduce Alzheimer's Risk
People who take a drug used to lower blood sugar levels in type 2 diabetes have less amyloid-beta in their brains, a bio ...
AUG 18, 2021
Neuroscience
Histamine Regulates Serotonin Levels in Depression
AUG 18, 2021
Histamine Regulates Serotonin Levels in Depression
Heightened histamine levels from inflammation inhibit the effects of the mood-regulating neurotransmitter serotonin in t ...
Loading Comments...